Summary
Loukas is a bioinformatician, who completed his PhD dissertation on the mathematical modelling of DNA methylation. He is currently employed as a research associate in molecular epidemiology at Imperial College London, and his work focuses on leveraging genetic data to identify causal risk factors for cardiovascular diseases, but also gain insight into various aspects of drug effects, such as exploring efficacy, repurposing opportunities and adverse effects of drugs that are being pursued in clinical development.
Publications
Journals
Dib M-J, Zagkos L, Meena D, et al., 2024, LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization Study., Stroke
Zagkos L, Schwinges A, Amin HA, et al., 2024, Exploring the contribution of lifestyle to the impact of education on the risk of cancer through Mendelian randomization analysis., Sci Rep, Vol:14
Dib M-J, Levin MG, Zhao L, et al., 2024, Proteomic Associations of Adverse Outcomes in Human Heart Failure., J Am Heart Assoc, Vol:13
Gagnon E, Daghlas I, Zagkos L, et al., 2024, Mendelian Randomization Applied to Neurology: Promises and Challenges., Neurology, Vol:102
Zagkos L, Cronjé HT, Woolf B, et al., 2024, Genetic investigation into the broad health implications of caffeine: evidence from phenome-wide, proteome-wide and metabolome-wide Mendelian randomization, Bmc Medicine, Vol:81, ISSN:1741-7015